Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Fri, 22 Mar 19 06:00:13 +0000 Fri, 22 Mar 19 06:00:13 +0000 Drug Shortages Continue to Be a Challenge The impact has been a continual struggle for pharmacies to provide adequate and appropriate patient care.&nbsp;&nbsp; Thu, 21 Mar 19 17:19:00 +0000 Medication Access Framework Identifies Social Determinants of Health The framework describes the cyclic nature of medication access, beginning with the patient&rsquo;s awareness of their illness or condition, and ending with adherence.&nbsp;<br /> &nbsp; Tue, 19 Mar 19 15:47:00 +0000 FDA Approves Atezolizumab Combination for Initial Treatment of Adults With ES-SCLC This approval is based on results from the Phase III IMpower133 study, which showed that atezolizumab in combination with chemotherapy helped people live significantly longer compared to chemotherapy alone in the intention-to-treat population. Tue, 19 Mar 19 10:00:00 +0000 Voluntary Nationwide Recall of Levoleucovorin Injection Levoleucovorin injection is being recalled due to the presence of copper salts discovered during a 12-month stability testing. Mon, 18 Mar 19 19:00:00 +0000 Match Day Pairs Thousands of Pharmacy Students With Residency Programs Over the last 5 years, post-graduate year-1 (PGY1) residency positions have grown by 34% and post-graduate year-2 (PGY2) positions by 64%.&nbsp; Fri, 15 Mar 19 21:18:00 +0000 Congress Needs to Know What Obstacles Prevent Pharmacists from Providing Quality Care Thu, 14 Mar 19 19:49:00 +0000 Medical Integration Provides Constant Day to Day Follow Up with Patients Wed, 13 Mar 19 16:14:00 +0000 Comparison Study for Iron Deficiency Anemia Treatment Yields Positive Results The study&rsquo;s results reveal that ferric maltol may offer efficiency and improved Hb levels for those with anemia. Wed, 13 Mar 19 14:04:00 +0000 Data and Patient Testimonies Drive Congress in Pharmacy Legislation Tue, 12 Mar 19 18:54:00 +0000 Fourth Trastuzumab Biosimilar Granted FDA Approval Trastuzumab is indicated for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Tue, 12 Mar 19 14:04:00 +0000 Pharmacists Are Happy With Their Salaries, Less So With Their Jobs, Survey Shows (Part 3) In late 2018,&nbsp;<em>Pharmacy Times&nbsp;</em>surveyed readers to determine their satisfaction levels with their jobs and salaries as pharmacists.&nbsp;<br /> &nbsp; Tue, 12 Mar 19 13:00:00 +0000 FDA OKs Dupilumab For Adolescent AD Dupilumab is now the first biologic therapy approved for the patient population. Mon, 11 Mar 19 20:46:00 +0000 The Value of Going Beyond the First Fill as a Medically Integrated Pharmacy Mon, 11 Mar 19 19:07:00 +0000 Importance of Collaboration in Ensuring Medication Compliance Mon, 11 Mar 19 18:53:00 +0000 FDA OKs First Immunotherapy Combo Regimen for Breast Cancer With this approval, atezolizumab plus&nbsp;nab-paclitaxel is the first cancer immunotherapy regimen to be approved for breast cancer. Fri, 08 Mar 19 21:25:00 +0000 Dupilumab sBLA Granted Priority Review for Chronic Rhinosinusitis with Nasal Polyps <em>Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps. </em><br /> &nbsp; Fri, 08 Mar 19 17:54:00 +0000 FDA Grants Breakthrough Designation to Chemotherapy-Free Combo Therapy for CLL Venetoclax (Venclexta) plus obinutuzumab (Gazyva) is being developed for patients with previously-untreated chronic lymphocytic leukemia and co-existing medical conditions.&nbsp; Thu, 07 Mar 19 15:55:00 +0000 ASHP Announces 2019 Award Recipients The awards will be presented at the ASHP&rsquo;s Summer Meetings and the 54th&nbsp;Midyear Clinical Meeting. Wed, 06 Mar 19 21:41:00 +0000 FDA Accepts Supplemental New Drug Application for Baloxavir Marboxil for Treating Flu in People at High Risk of Complications The sNDA is based on results from the phase 3 CAPSTONE-2 study of a single dose of Xofluza compared with placebo or oseltamivir 75 mg, twice daily for 5 days, in people 12 years of age or older who are at high risk of complications from the flu. Wed, 06 Mar 19 20:18:00 +0000 Priority Review Granted for Treatment of Episodic Cluster Headache in Adults The Priority Review is set to fast-track an application of a drug that may potentially represent a significant advancement in treatment for a serious condition. Wed, 06 Mar 19 14:00:00 +0000 FDA Commissioner Announces His Resignation From the Agency FDA Commissioner Scott Gottlieb, MD, cited that he was &ldquo;missing&rdquo; his family as the reason for his impending departure. Tue, 05 Mar 19 23:14:00 +0000 CDC Emphasizes Prevention Efforts to Stop Growing Trend of Staph Infections The CDC urges health care providers to implement its recommendations and to regularly review their facility infection data, among other intervention methods.<br /> &nbsp; Tue, 05 Mar 19 20:21:00 +0000 Advocacy Group Seeks Personal Injury Lawyers for People Injured by Pharmacy Errors In a statement, the group said it conducted a half-year investigation into pharmacies dispensing prescriptions to the wrong people, and has found that a significant enough problem exists nationwide to warrant the action. Tue, 05 Mar 19 15:16:00 +0000 Health Systems Share Their Approaches to Improve Patient Engagement In one example cited in the paper, officials with Ochsner Health System reported using their online patient portal to help treat hypertension with a novel digital medicine program that combined patient-reported blood pressure data, clinical data, and coaching. Tue, 05 Mar 19 09:50:00 +0000 Report: Higher Health Care Spending Caused by Rising Prices, Not Utilization The 2017 Health Care Cost and Utilization Report examined medical and prescription drug spending, utilization, and average prices using health care claims data from 2013 through 2017 for Americans under the age of 65 who were covered by employer-sponsored insurance. Mon, 04 Mar 19 19:38:00 +0000